Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [A fatality caused by heparin overdose].

Literature DB >> 2609791

[A fatality caused by heparin overdose].

Abstract

Because of suspected pulmonary embolism 550.000 I.U. of heparin were administered instead of 55.000 I.U. of heparin within 24 h to a 62 year old patient. The man died because of cerebral hemorrhage the following day. Autopsy findings are reported and difficulties in medical expertise are discussed.

Entities: Chemical Disease Species

Mesh：

Substances：
Heparin

Year: 1989 PMID： 2609791 DOI： 10.1007/bf01258919

Source DB: PubMed Journal: Z Rechtsmed ISSN： 0044-3433

Keyword Cloud
References

14 in total

1. Management of heparin therapy: Controlled prospective trial.

Authors: E W Salzman; D Deykin; R M Shapiro; R Rosenberg
Journal: N Engl J Med Date: 1975-05-15 Impact factor: 91.245

Review 2. Some side effects of heparin, heparinoids, and their antagonists.

Authors: W W Coon; P W Willis
Journal: Clin Pharmacol Ther Date: 1966 May-Jun Impact factor: 6.875

3. Adrenal hemorrhage during anticoagulant therapy. A clinical and pathological study of ten cases.

Authors: E Amador
Journal: Ann Intern Med Date: 1965-10 Impact factor: 25.391

4. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.

Authors: R D Hull; G E Raskob; J Hirsh; R M Jay; J R Leclerc; W H Geerts; D Rosenbloom; D L Sackett; C Anderson; L Harrison
Journal: N Engl J Med Date: 1986-10-30 Impact factor: 91.245

5. Drug-induced gastrointestinal bleeding. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center.

Authors: H Jick; J Porter
Journal: Lancet Date: 1978-07-08 Impact factor: 79.321

[A fatality caused by heparin overdose].

1. Management of heparin therapy: Controlled prospective trial.

Review 2. Some side effects of heparin, heparinoids, and their antagonists.

3. Adrenal hemorrhage during anticoagulant therapy. A clinical and pathological study of ten cases.

4. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.

5. Drug-induced gastrointestinal bleeding. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center.

6. Heparin kinetics in venous thrombosis and pulmonary embolism.

7. Heparin therapy for stroke: hemorrhagic complications and risk factors for intracerebral hemorrhage.

8. Randomized prospective trial of continuous vs intermittent heparin therapy.

9. Haemorrhagic complications of heparin therapy.

10. Predictors of bleeding during heparin therapy.